Halozyme Therapeutics | HALO - Lngresos Netos





Lngresos Netos Cambio Fecha
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amarin USD -1.22M 6.51M 2025-12
Amgen USD 2.38B 556M 2026-06
Baxter International USD 126M 141M 2026-06
Cara Therapeutics USD -6.8M 1.28M 2026-03
Cytokinetics USD -198.76M 7.27M 2026-06
DBV Technologies USD -47.6M 2.77M 2026-03
Eli Lilly USD 7.1B 301M 2026-06
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
MannKind USD -16.62M 671K 2026-03
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Pfizer USD -248M 2.94B 2026-06
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
United Therapeutics USD 333M 58.1M 2026-06
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12